Clinical Efficacy of Glucosamine Plus Diacerein Versus Mono-therapy of Glucosamine
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare pain scores, WOMAC total and subscores, actual and
change of joint space width and the rate of gastrointestinal side effects at 4, 8, 12, and 24
weeks between dual-therapy of diacerein and glucosamine versus a mono-therapy of glucosamine
in OA patients